用补充监测系统监测SARS-CoV-2变种:法国Omicron JN.1变种的风险评估,2023年8月至2024年1月
Adriana Traore1, Kelly Charniga2, Sophie Grellet3,4
1Direction des Maladies Infectieuses, Santé publique France, Saint-Maurice, France.
概括
通过结合监测方法实现了SARS-CoV-2 JN.1变种的早期检测. 尽管存在遗传差异,但与之前的变种相比,JN.1的公共卫生影响没有增加.
科学领域:
- 病毒学 病毒学
- 流行病学 流行病学
- 公共卫生 公共卫生
背景情况:
- 早期检测和特征SARS-CoV-2变种对于公共卫生至关重要.
- 由于遗传差异和流行率增加,对BA.2.86及其子系JN.1进行了加强的监测.
研究的目的:
- 为了全面描述SARS-CoV-2亚系JN.1.的特征.
- 详细说明结合使用流行病学和实验室数据,调查和建模用于变种表征的细节.
主要方法:
- 通过流行病学调查和常规/新型监测系统 (RELAB网络) 收集数据.
- 与之前的变种 (EG.5,BA.4/BA.5,其他BA.2.86亚系) 进行JN.1病例的比较.
- 估计JN.1的增长速度和翻倍时间.
主要成果:
- JN.1首次在2023年9月在法国法兰西岛检测到,并在全国范围内传播.
- 估计的翻倍时间在区域范围内从8.6到26.4天不等.
- 与之前的变体相比,JN.1病例表现出类似的人口统计,住院率和RT-PCR Ct值,具有明显的症状,如更高的厌氧频率.
结论:
- 综合数据来源是检测新出现的JN.1变种的关键.
- 尽管有遗传差异,但JN.1没有显示出增加公共卫生影响的证据.
- 综合监测有效地描述了该变种的传播和特征.
关键词:
BA.2.86 BA.2.86 是一个在 COVID-19 疫情中,在 JN.1 里面,你会看到 JN.1 .这种SARS-CoV-2的变种.基因组监测对基因组进行监测.实验室网络的实验室网络.更多相关视频
相关概念视频
Principles of Disease Surveillance
69
Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
69
Relative Risk
116
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
116
Transmission-based Precautions II: Airborne and Protective Environment
1.2K
Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.2K
Pharmacovigilance
771
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
771
Steps in Outbreak Investigation
105
In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:
105
Viral Mutations
32.1K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
32.1K


